SOLVENTUM CORPORATION Selling, General and Administrative Expense
SOLVENTUM CORPORATION (SOLV) reported Selling, General and Administrative Expense of $927.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-08-05
- SOLVENTUM CORPORATION selling, general and administrative expense for the quarter ending 2026-06-30 was $927.00M, a 20.08% increase year-over-year.
- SOLVENTUM CORPORATION selling, general and administrative expense for the quarter ending 2026-03-31 was $827.00M, a 7.54% increase year-over-year.
- SOLVENTUM CORPORATION selling, general and administrative expense for the quarter ending 2025-12-31 was $759.00M, a 3.19% decline year-over-year.
- SOLVENTUM CORPORATION selling, general and administrative expense for the quarter ending 2025-09-30 was $780.00M, a 11.27% increase year-over-year.
- SOLVENTUM CORPORATION selling, general and administrative expense for fiscal 2025 was $3.08B, a 10.71% increase from fiscal 2024.
- SOLVENTUM CORPORATION selling, general and administrative expense for fiscal 2024 was $2.78B, a 21.01% increase from fiscal 2023.
- SOLVENTUM CORPORATION selling, general and administrative expense for fiscal 2023 was $2.30B, a 2.86% increase from fiscal 2022.
- SOLVENTUM CORPORATION selling, general and administrative expense for fiscal 2022 was $2.23B.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month | Selling, General and Administrative Expense 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $927.00M 10-Q · filed 2026-08-05 | $1.75B 10-Q · filed 2026-08-05 | $2.51B derived: sum of 3 quarters · filed 2026-08-05 | $3.29B derived: sum of 4 quarters · filed 2026-08-05 | |
| 2026-03-31 | $827.00M 10-Q · filed 2026-05-05 | $1.59B derived: sum of 2 quarters · filed 2026-05-05 | $2.37B derived: sum of 3 quarters · filed 2026-05-05 | $3.14B derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-12-31 | $759.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $1.54B derived: sum of 2 quarters · filed 2026-02-27 | $2.31B derived: sum of 3 quarters · filed 2026-08-05 | $3.08B 10-K · filed 2026-02-27 | |
| 2025-09-30 | $780.00M 10-Q · filed 2025-11-06 | $1.55B derived: sum of 2 quarters · filed 2026-08-05 | $2.32B 10-Q · filed 2025-11-06 | $3.10B derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-06-30 | $772.00M 10-Q · filed 2026-08-05 | $1.54B 10-Q · filed 2026-08-05 | $2.33B derived: sum of 3 quarters · filed 2026-08-05 | $3.03B derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-03-31 | $769.00M 10-Q · filed 2026-05-05 | $1.55B derived: sum of 2 quarters · filed 2026-05-05 | $2.25B derived: sum of 3 quarters · filed 2026-05-05 | $2.96B derived: sum of 4 quarters · filed 2026-05-05 | |
| 2024-12-31 | $784.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $1.49B derived: sum of 2 quarters · filed 2026-02-27 | $2.19B derived: sum of 3 quarters · filed 2026-02-27 | $2.78B 10-K · filed 2026-02-27 | |
| 2024-09-30 | $701.00M 10-Q · filed 2025-11-06 | $1.40B derived: sum of 2 quarters · filed 2025-11-06 | $2.00B 10-Q · filed 2025-11-06 | $2.62B derived: sum of 4 quarters · filed 2026-02-27 | |
| 2024-06-30 | $701.00M 10-Q · filed 2025-08-08 | $1.30B 10-Q · filed 2025-08-08 | $1.92B derived: sum of 3 quarters · filed 2026-02-27 | $2.44B derived: sum of 4 quarters · filed 2026-02-27 | |
| 2024-03-31 | $596.00M 10-Q · filed 2025-05-09 | $1.21B derived: sum of 2 quarters · filed 2026-02-27 | $1.74B derived: sum of 3 quarters · filed 2026-02-27 | $2.32B derived: sum of 4 quarters · filed 2026-02-27 | |
| 2023-12-31 | $618.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $1.14B derived: sum of 2 quarters · filed 2026-02-27 | $1.72B derived: sum of 3 quarters · filed 2026-02-27 | $2.30B 10-K · filed 2026-02-27 | $2.24B 10-K · filed 2025-02-28 |
| 2023-09-30 | $525.00M 10-Q · filed 2024-11-08 | $1.10B derived: sum of 2 quarters · filed 2024-11-08 | $1.68B 10-Q · filed 2024-11-08 | ||
| 2023-06-30 | $579.00M 10-Q · filed 2024-08-09 | $1.16B 10-Q · filed 2024-08-09 | |||
| 2023-03-31 | $577.00M 10-Q · filed 2024-05-10 | ||||
| 2022-12-31 | $2.23B 10-K · filed 2025-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |